News

“Effective and consistent efforts as well as courage to implement an original business concept and the introduction of an innovative solution into the market” – that is how the Marshal Office of the Lower Silesia Province justified the nomination of Patrycja Wizińska-Socha, CEO at Nestmedic, for the Jan Wejchert Award of the Polish Business Roundtable. The local government officials nominated the CEO of the Wrocław-based company in the category of “Vision and innovations”. Patrycja Wizińska-Socha is a person fully determined to reach her goals and the best proof of that is Pregnabit, a certified medical product offered along with the service of the Telemonitoring Medical Centre.. The firmness of purpose and hard work of Patrycja Wizińska-Socha have already earned her numerous awards and recognition, say the representatives of the Marshal Office. The award of the Polish Business Roundtable is one of the most prestigious distinctions in Poland. It is received by people whose innovative concepts and visions make the world a better place. We recognise personalities who use their drive and business acumen to break the mould, create new standards and set trends. It is an award for the people of tomorrow who shape our future today, say the members of the jury. Last year, the award was granted to Professor Krystian Jażdżewski together with the team of physicians and scientists from the Centre of New Technologies at the University of Warsaw and from the University’s spin-off, Warsaw Genomics, for developing the methodology of the most advanced genetic tests based on genome sequencing. This year’s winners will be announced on 21 May at the award ceremony. More information at http://nagrodaprb.pl/

Turn on TVP1 – Polish TV Channel 1 – this Sunday, 28 January, at 9:15am. The Pregnabit system will be presented by Patrycja Wizińska-Socha, CEO at Nestmedic, in the new episode of “Jak to działa?” (How does it work?). The host of this popular science TV show is Radek Brzózka, who explores the mysteries and ins and outs of interesting everyday devices as well as natural phenomena. Using them as examples, he explains the basic laws of physics in the world around us. This time, Radek Brzózka takes a closer look at the cutting-edge achievement in telemedicine: teleCTG Pregnabit. You will see how our system works and why such solutions revolutionise contemporary medicine.  

The Pregnabit system will be tested by the leading provider of telemedicine solutions in Norway. This is the start of the company’s product commercialization in Northern Europe. We have just signed our first business partnership contract in Scandinavia. Our Norwegian telemedicine partner, Dignio AS Aksjeselskap, will test the Pregnabit device for the mobile CTG along with the dedicated platform for display and analysis of teleCTG results. Norway is the fourth country in the world as regards the highest expenditure on healthcare per capita (USD 6,700 per person according to OECD Health Statistics 2017). Therefore it is one of the strategic markets for Nestmedic. The international expansion of Nestmedic is gaining momentum. Recently, we have started collaborating with a partner in Germany, now we are entering Norway. It is a country with high spending on telemedicine and impressive birth rate in the European context, says Patrycja Wizińska-Socha, M.D., CEO at Nestmedic. Dignio provides telemedicine solutions to suppliers of healthcare services, e.g. hospitals, clinics and in-home nurses. The company has been operating for nearly 8 years and it offers products for people suffering from high blood pressure, diabetes and cardiovascular diseases. In collaboration with Nestmedic, it will provide state-of-the-art solutions to pregnant women. In 2016, Dignio increased sales by 76% YOY. The Scandinavian market presents great prospects due to the geography of the land which makes telemedicine solutions indispensable. They are regularly used by 75% of Norwegian hospitals and in the northern parts of the country it is 100%, explains Anna Skotny, M.D., General Manager and Co-founder of Nestmedic. The telemedicine market in Norway is actively supported by the Norwegian government. In 2016, the E-Health Department was established as the agency responsible for development and management of electronic collaboration in the sector of healthcare and welfare. At present, more than 80% of medical devices used in Norway are imported. Expenditure on healthcare in Norway amounts to one of the highest in the world and is reflected in the share of the Gross Domestic Product at 10.5% (in Poland it was 6.4%; OECD Health Statistics 2017).